Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro

Experimental Cell Research

Volumn 280, Issue 2, 2002, Pages 179-191

  Tille, Jean Christophe ^a   Pepper, Michael S ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Angiogenesis; Collagen; Endothelium; FGF 2; Mesenchyme; VEGF A

Indexed keywords

ANGIOPOIETIN 1; BATIMASTAT; CGP 51376; CGP 53176; COLLAGEN DERIVATIVE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; LIGAND; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT VASCULOTROPIN; SEMAXANIB; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VFM 17; VFM 23A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CONTACT; CELL INTERACTION; CELL TYPE; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME INHIBITION; IN VITRO STUDY; MESENCHYME CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

EID: 0036431919     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5635     Document Type: Article

References (58)

1. Conway, E. M., Collen, D., and Carmeliet, P. (2001). Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521.
2. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
3. Nicosia, R. F., and Villaschi, S. (1999). Autoregulation of angiogenesis by cells of the vessel wall. Int. Rev. Cytol. 185, 1-43.
4. Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280, C1358-C1366.
5. Benjamin, L. E., Hemo, I., and Keshet, E. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598.
6. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028.
7. Gerwins, P., Skoldenberg, E., and Claesson-Welsh, L. (2000). Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol. 34, 185-194.
8. Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, II365-II371.
9. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1992). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824-831.
10. Mandriota, S. J., and Pepper, M. S. (1997). Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J. Cell Sci. 110 (Pt. 18), 2293-2302.
11. Hellstrom, M., Kaln, M., Lindahl, P., Abramsson, A., and Betsholtz, C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055.
12. Lindahl, P., Johansson, B. R., Leveen, P., and Betsholtz, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
13. Soriano, P. (1994). Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8, 1888-1896.
14. Loughna, S., and Sato, T. N. (2001). Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol. 20, 319-325.
15. Nicosia, R. F., and Ottinetti, A. (1990). Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell. Dev. Biol. 26, 119-128.
16. Nehls, V., Denzer, K., and Drenckhahn, D. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 270, 469-474.
17. Sato, Y., and Rifkin, D. B. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109, 309-315.
18. Orlidge, A., and D'Amore, P. A. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
19. Sato, Y., Tsuboi, R., Lyons, R., Moses, H., and Rifkin, D. B. (1990). Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J. Cell Biol. 111, 757-763.
20. Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R., and D'Amore, P. A. (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
21. Taylor, S. M., and Jones, P. A. (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17, 771-779.
22. Hirschi, K. K., Rohovsky, S. A., and D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141, 805-814.
23. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
24. Furie, M. B., Cramer, E. B., Naprstek, B. L., and Silverstein, S. C. (1984). Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol. 98, 1033-1041.
25. Pepper, M. S., Montesano, R., el Aoumari, A., Gros, D., Orci, L., and Meda, P. (1992). Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 262, C1246-C1257.
26. Montesano, R., and Orci, L. (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.
27. Montesano, R., Orci, L., and Vassalli, P. (1983). In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell Biol. 97, 1648-1652.
28. Gorden, D. L., Mandriota, S. J., Montesano, R., Orci, L., and Pepper, M. S. (1997). Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation 63, 436-434.
29. Mandriota, S. J., and Pepper, M. S. (1998). Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83, 852-859.
30. Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J. D. (1990). Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
31. Montesano, R., Pepper, M. S., and Orci, L. (1993). Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J. Cell Sci. 105 (Pt. 4), 1013-1024.
32. Pepper, M. S., and Mandriota, S. J. (1998). Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp. Cell Res. 241, 414-425.
33. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30343.
34. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., and Ferrara, N. (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271, 5638-5646.
35. Fong, T. A., Shawver, L. K., Sun, L., Tang, C., App. H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., and McMahon, G. (1999). SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99-106.
36. Mendel, D. B., Laird, A. D., Smolich, B. D., Blake, R. A., Liang, C., Hannah, A. L., Shaheen, R. M., Ellis, L. M., Weitman, S., Shawver, L. K., and Cherrington, J. M. (2000). Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des. 15, 29-41.
37. Ma, D. H., Tsai, R. J., Chu, W. K., Kao, C. H., and Chen, J. K. (1999). Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest. Ophthalmol. Vis. Sci. 40, 1822-1828.
38. Kuzuya, M., Satake, S., Esaki, T., Yamada, K., Hayashi, T., Naito, M., Asai, K., and Iguchi, A. (1995). Induction of angiogenesis by smooth muscle cell-derived factor: Possible role in neovascularization in atherosclerotic plaque. J. Cell Physiol. 164, 658-667.
39. Pepper, M. S., Vassalli, J. D., Orci, L., and Montesano, R. (1993). Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp. Cell Res. 204, 356-363.
40. Nicosia, R. F., Nicosia, S. V., and Smith, M. (1994). Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 145, 1023-1029.
41. Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., and Heldin, C. H. (1992). Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7, 261-266.
42. Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R., and D'Amore, P. A. (1999). Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84, 298-305.
43. Arkonac, B. M., Foster, L. C., Sibinga, N. E., Patterson, C., Lai, K., Tsai, J. C., Lee, M. E., Perrella, M. A., and Haber, E. (1998). Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J. Biol. Chem. 273, 4400-4405.
44. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Muller, M., Druker, B. J., and Lydon, N. B. (1996). Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylamin-opyrimidine derivative. Cancer Res. 56, 100-104.
45. Papapetropoulos, A., Garcia-Cardena, G., Dengler, T. J., Maisonpierre, P. C., Yancopoulos, G. D., and Sessa, W. C. (1999). Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 79, 213-223.
46. Koblizek, T. I., Weiss, C., Yancopoulos, G. D., Deutsch, U., and Risau, W. (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8, 529-532.
47. Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G. D., and Isner, J. M. (1998). Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83, 233-240.
48. Murohara, T., Witzenbichler, B., Spyridopoulos, I., Asahara, T., Ding, B., Sullivan, A., Losordo, D. W., and Isner, J. M. (1999). Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 19, 1156-1161.
49. Shizukuda, Y., Tang, S., Yokota, R., and Ware, J. A. (1999). Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity. Circ. Res. 85, 247-256.
50. Montrucchio, G., Lupia, E., de Martino, A., Battaglia, E., Arese, M., Tizzani, A., Bussolino, F., and Camussi, G. (1997). Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am. J. Pathol. 151, 557-563.
51. Babaei, S., Teichert-Kuliszewska, K., Monge, J. C., Mohamed, F., Bendeck, M. P., and Stewart, D. J. (1998). Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ. Res. 82, 1007-1015.
52. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., and Bicknell, R. (1997). Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99, 2625-2634.
53. Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A., and Sessa, W. C. (1997). Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139.
54. Hood, J. D., Meininger, C. J., Ziche, M., and Granger, H. J. (1998). VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol. 274, H1054-H1058.
55. Pepper, M. S. (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104-1117.
56. Wang, H., and Keiser, J. A. (1998). Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ. Res. 83, 832-840.
57. Davies, B., Brown, P. D., East, N., Crimmin, M. J., and Balkwill, F. R. (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53, 2087-2091.
58. Satake, S., Kuzuya, M., Ramos, M. A., Kanda, S., and Iguchi, A. (1998). Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice. Biochem. Biophys. Res. Commun. 244, 642-664.